Zhiwei Wang

Hefei, 230032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Targeted serum metabolomics reveals alterations in amino acid and neurotransmitter pathways in Parkinson's disease.

Targeted serum metabolomics reveals alterations in amino acid and neurotransmitter pathways in Parkinson's disease.

Journal: The Analyst

Published: February 17, 2026

A novel plasma cell infiltration-associated prognostic signature suggests a potential role for CABP4 in glioma progression.

A novel plasma cell infiltration-associated prognostic signature suggests a potential role for CABP4 in glioma progression.

Journal: Brain research

Published: September 04, 2025

Determination of temozolomide and its metabolite 5-aminoimidazole-4-carboxamide in plasma using UPLC-MS/MS: Implications for therapeutic drug monitoring with high-grade gliomas.

Determination of temozolomide and its metabolite 5-aminoimidazole-4-carboxamide in plasma using UPLC-MS/MS: Implications for therapeutic drug monitoring with high-grade gliomas.

Journal: Journal of pharmaceutical and biomedical analysis

Published: May 30, 2025

Correction: SCFFBXW7/GSK3β-Mediated GFI1 Degradation Suppresses Proliferation of Gastric Cancer Cells.

Correction: SCFFBXW7/GSK3β-Mediated GFI1 Degradation Suppresses Proliferation of Gastric Cancer Cells.

Journal: Cancer research

Published: March 07, 2025

Publisher Correction to: RAB37 suppresses the EMT, migration and invasion of gastric cancer cells by mediating autophagic degradation of β-catenin.

Publisher Correction to: RAB37 suppresses the EMT, migration and invasion of gastric cancer cells by mediating autophagic degradation of β-catenin.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: December 31, 2024

RAB37 suppresses the EMT, migration and invasion of gastric cancer cells by mediating autophagic degradation of β-catenin.

RAB37 suppresses the EMT, migration and invasion of gastric cancer cells by mediating autophagic degradation of β-catenin.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: December 11, 2024

The role and application of small extracellular vesicles in glioma.

The role and application of small extracellular vesicles in glioma.

Journal: Cancer cell international

Published: January 08, 2024

A novel disulfide death-related genes prognostic signature identifies the role of IPO4 in glioma progression.

A novel disulfide death-related genes prognostic signature identifies the role of IPO4 in glioma progression.

Journal: Cancer cell international

Published: November 06, 2023

Study protocol: a core outcome set for perioperative exercise clinical effectiveness trials for lung cancer patients.

Study protocol: a core outcome set for perioperative exercise clinical effectiveness trials for lung cancer patients.

Journal: Trials

Published: September 12, 2023

Online dynamic nomogram for predicting pain recurrence after microvascular decompression in trigeminal neuralgia.

Online dynamic nomogram for predicting pain recurrence after microvascular decompression in trigeminal neuralgia.

Journal: Experimental and therapeutic medicine

Published: February 24, 2023

Integrative analysis of a novel 5 methylated snoRNA genes prognostic signature in patients with glioma.

Integrative analysis of a novel 5 methylated snoRNA genes prognostic signature in patients with glioma.

Journal: Epigenomics

Published: October 12, 2022

A Novel Defined Pyroptosis-Related Gene Signature for Predicting Prognosis and Treatment of Glioma.

A Novel Defined Pyroptosis-Related Gene Signature for Predicting Prognosis and Treatment of Glioma.

Journal: Frontiers in oncology

Published: May 31, 2021

Showing 1-12 of 12

Last Updated: 09/26/2026